Suppr超能文献

癫痫单药治疗试验中的多种治疗比较

Multiple treatment comparisons in epilepsy monotherapy trials.

作者信息

Tudur Smith Catrin, Marson Anthony G, Chadwick David W, Williamson Paula R

机构信息

Centre for Medical Statististcs and Health Evaluation, University of Liverpool, Liverpool, UK.

出版信息

Trials. 2007 Nov 5;8:34. doi: 10.1186/1745-6215-8-34.

Abstract

BACKGROUND

The choice of antiepileptic drug for an individual should be based upon the highest quality evidence regarding potential benefits and harms of the available treatments. Systematic reviews and meta-analysis of randomised controlled trials should be a major source of evidence supporting this decision making process. We summarise all available individual patient data evidence from randomised controlled trials that compared at least two out of eight antiepileptic drugs given as monotherapy.

METHODS

Multiple treatment comparisons from epilepsy monotherapy trials were synthesized in a single stratified Cox regression model adjusted for treatment by epilepsy type interactions and making use of direct and indirect evidence. Primary outcomes were time to treatment failure and time to 12 month remission from seizures. A secondary outcome was time to first seizure.

RESULTS

Individual patient data for 6418 patients from 20 randomised trials comparing eight antiepileptic drugs were synthesized. For partial onset seizures (4628 (72%) patients), lamotrigine, carbamazepine and oxcarbazepine provide the best combination of seizure control and treatment failure. Lamotrigine is clinically superior to all other drugs for treatment failure but estimates suggest a disadvantage compared to carbamazepine for time to 12 month remission [Hazard Ratio (95% Confidence Interval) = 0.87(0.73 to 1.04)] and time to first seizure [1.29(1.13 to 1.48)]. Phenobarbitone may delay time to first seizure [0.77(0.61 to 0.96)] but at the expense of increased treatment failure [1.60(1.22 to 2.10)]. For generalized onset tonic clonic seizures (1790 (28%) patients) estimates suggest valproate or phenytoin may provide the best combination of seizure control and treatment failure but some uncertainty remains about the relative effectiveness of other drugs.

CONCLUSION

For patients with partial onset seizures, results favour carbamazepine, oxcarbazepine and lamotrigine. For generalized onset tonic clonic seizures, results favour valproate and phenytoin.

摘要

背景

为个体选择抗癫痫药物应基于有关现有治疗潜在益处和危害的最高质量证据。随机对照试验的系统评价和荟萃分析应是支持这一决策过程的主要证据来源。我们汇总了来自随机对照试验的所有可用个体患者数据证据,这些试验比较了八种作为单一疗法使用的抗癫痫药物中的至少两种。

方法

癫痫单一疗法试验的多种治疗比较在一个分层Cox回归模型中进行综合,该模型针对癫痫类型相互作用进行了治疗调整,并利用了直接和间接证据。主要结局是治疗失败时间和癫痫发作12个月缓解时间。次要结局是首次癫痫发作时间。

结果

汇总了来自20项比较八种抗癫痫药物的随机试验的6418例患者的个体患者数据。对于部分性发作(4628例(72%)患者),拉莫三嗪、卡马西平和奥卡西平在癫痫控制和治疗失败方面提供了最佳组合。拉莫三嗪在治疗失败方面在临床上优于所有其他药物,但估计表明与卡马西平相比,在癫痫发作12个月缓解时间[风险比(95%置信区间)=0.87(0.73至1.04)]和首次癫痫发作时间[1.29(1.13至1.48)]方面存在劣势。苯巴比妥可能会延迟首次癫痫发作时间[0.77(0.61至0.96)],但代价是治疗失败增加[1.60(1.22至2.10)]。对于全面性强直阵挛发作(1790例(28%)患者),估计表明丙戊酸盐或苯妥英钠可能在癫痫控制和治疗失败方面提供最佳组合,但其他药物的相对有效性仍存在一些不确定性。

结论

对于部分性发作患者,结果支持卡马西平、奥卡西平和拉莫三嗪。对于全面性强直阵挛发作,结果支持丙戊酸盐和苯妥英钠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ef/2194733/7006a50cd8eb/1745-6215-8-34-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验